FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On September 27, 2006
Table of Contents
Docket # Title
1995S-0158 Community Disclosure of Institutional Review Boards
2004N-0234 Annual Guidance Agenda
2004P-0349 Action on Products containing added Mercury
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
2005N-0403 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
2005P-0377 Petition to Rescind the "Generally Recognized as Safe" or GRAS Status for Aluminum Based Food Additives
2006E-0006 Patent Extension Application for Lyrica (pregabalin), U.S. Patent No. 6,197,819
2006M-0148 P040028 - LUMA Cervical Imaging System
2006M-0161 Premarket Approval for Ceralas I Laser System and Ceralink Slit Lamp Adapter by QLT USA, Inc., P050021
2006M-0162 Quantel Activis Laser and ZSL30 ACT, and HSBMBQ ACT Slit Lamp Adapters by - QLT USA, Inc.
2006M-0193 P040033 - Birmingham Hip Resurfacing (BHR) System
2006M-0199 P030008/S004 - WaveLight ALLEGRETTO WAVE Excimer Laser System
2006M-0200 P050012 - DexCom STS Continuous Glucose Monitoring System
2006M-0235 P050047 - Juvederm 24HV, Juvederm 30, and Juvederm 30HV Gel Implants
2006M-0264 Premarket Approval: P040052 -MonoPrep Pap Test (MPPT)
2006N-0107 FDA-Regulated Products Containing Nanotechnology Materials
2006N-0283 Agency Information Collection Activities; Proposed Collection; Comment Request; FDA Survey of Physicians Perceptions of the Impact of Early Risk Communication about Medical Products
2006P-0124 Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
2006P-0394 To take regulatory action to revise the labeling requirements for eggs sold in the United States
1995S-0158 Community Disclosure of Institutional Review Boards
RPT 20 University of Texas Health Science Center at San Antonio Vol #: 19
2004N-0234 Annual Guidance Agenda
EC 4 Valley High School Vol #: 1
2004P-0349 Action on Products containing added Mercury
PDN 1 FDA to Coalition for Mercury-free Drugs (CoMeD) Vol #: 1
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
MO 19 TMJ Implants, Inc. Vol #: 6
2005N-0403 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
EC 2 Animal Health Institute Vol #: 3
2005P-0377 Petition to Rescind the "Generally Recognized as Safe" or GRAS Status for Aluminum Based Food Additives
SUP 17 Department of the Planet Earth Vol #: 5
2006E-0006 Patent Extension Application for Lyrica (pregabalin), U.S. Patent No. 6,197,819
N 1 FDA Vol #: 1
2006M-0148 P040028 - LUMA Cervical Imaging System
NAL 1 FDA Vol #: 1
2006M-0161 Premarket Approval for Ceralas I Laser System and Ceralink Slit Lamp Adapter by QLT USA, Inc., P050021
NAL 1 FDA Vol #: 1
2006M-0162 Quantel Activis Laser and ZSL30 ACT, and HSBMBQ ACT Slit Lamp Adapters by - QLT USA, Inc.
NAL 1 FDA Vol #: 1
2006M-0193 P040033 - Birmingham Hip Resurfacing (BHR) System
NAL 1 FDA Vol #: 1
2006M-0199 P030008/S004 - WaveLight ALLEGRETTO WAVE Excimer Laser System
NAL 1 FDA Vol #: 1
2006M-0200 P050012 - DexCom STS Continuous Glucose Monitoring System
NAL 1 FDA Vol #: 1
2006M-0235 P050047 - Juvederm 24HV, Juvederm 30, and Juvederm 30HV Gel Implants
NAL 1 FDA Vol #: 1
2006M-0264 Premarket Approval: P040052 -MonoPrep Pap Test (MPPT)
NAL 1 FDA Vol #: 1
2006N-0107 FDA-Regulated Products Containing Nanotechnology Materials
C 4 C. Pelsor Vol #: 1
C 5 R. Knablin Vol #: 1
2006N-0283 Agency Information Collection Activities; Proposed Collection; Comment Request; FDA Survey of Physicians Perceptions of the Impact of Early Risk Communication about Medical Products
C 2 Scientific Advantage, LLC Vol #: 1
2006P-0124 Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
SUP 3 ViroPharma Incorporated (ViroPharma) Vol #: 1
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
EC 710 NAPPII./NAPI./NAP INC. Vol #: 5
2006P-0394 To take regulatory action to revise the labeling requirements for eggs sold in the United States
ACK 1 FDA/DDM to Compassion Over Killing, Inc. Vol #: 1
CP 1 Compassion Over Killing, Inc. Vol #: 1

Page created on January 16, 2007 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management